ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.585,93
0,35%
S&P 500
6.046,62
0,14%
Dow Jones
44.710,71
0,35%
Euro vs US Dollar
1,04199
0,46%
Bitcoin
96.934,38
-0,96%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Corcept Therapeutics Inc (CORT) Börsenkurse

Corcept Therapeutics Inc

Corcept Therapeutics Inc (CORT)

NASDAQ
68,05
1,14
( 1,70% )
Aktualisiert: 18:59:54
Verzögert um 15 Minuten

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
68,05
Gebot
68,01
Fragen
68,06
Volumen
216.326
66,78 Tagesbereich 68,50
20,84 52-Wochen-Bereich 71,29
Marktkapitalisierung
7,13B
Handelsende
66,91
Handelsbeginn
67,02
Letzte Trade
8
@
68.045
Letzter Handelszeitpunkt
19:00:03
Finanzvolumen
US$ 14.676.760
VWAP
67,8456
Durchschnittliches Volumen (3 Mio.)
837.670
Ausgegebene Aktien
104.775.137
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
67,34
Gewinn pro Aktie (EPS)
1,01
Erlöse
482,38M
Nettogewinn
106,14M

Über Corcept Therapeutics Inc

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.corcept.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Corcept Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CORT. The last closing price for Corcept Therapeutics was US$66,91. Over the last year, Corcept Therapeutics shares have traded in a share price range of US$ 20,84 to US$ 71,29.

Corcept Therapeutics currently has 104.775.137 shares in issue. The market capitalisation of Corcept Therapeutics is US$7,01 billion. Corcept Therapeutics has a price to earnings ratio (PE ratio) of 67.34.

CORT Neueste Nachrichten

Weitere Nachrichten

Form 144 - Report of proposed sale of securities

03 Februar 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

03 Februar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

25 Januar 2025
Edgar (US Regulatory)

Kuehn Law Encourages Investors of Corcept Therapeutics Inc. to Contact Law Firm

Kuehn Law Encourages Investors of Corcept Therapeutics Inc. to Contact Law Firm PR Newswire NEW YORK, Jan. 24, 2025 NEW YORK, Jan. 24, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder...

24 Januar 2025
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

15 Januar 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

10 Januar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

07 Januar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

07 Januar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

07 Januar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

03 Januar 2025
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
17.6612.684219241660.3971.2960.06114525667.41649089CS
417.14533.680385030950.90571.294990951060.31831197CS
129.917.024935511658.1571.294983767056.83014482CS
2634.975105.7445200333.07571.2933.07586848749.48296613CS
5246.47215.33827618221.5871.2920.8499009237.14879853CS
15648.66250.95410005219.3971.2917.1988176829.20484003CS
26055421.45593869713.0571.299.799099024.28439395CS

CORT - Frequently Asked Questions (FAQ)

What is the current Corcept Therapeutics share price?
The current share price of Corcept Therapeutics is US$ 68,05
How many Corcept Therapeutics shares are in issue?
Corcept Therapeutics has 104.775.137 shares in issue
What is the market cap of Corcept Therapeutics?
The market capitalisation of Corcept Therapeutics is USD 7,01B
What is the 1 year trading range for Corcept Therapeutics share price?
Corcept Therapeutics has traded in the range of US$ 20,84 to US$ 71,29 during the past year
What is the PE ratio of Corcept Therapeutics?
The price to earnings ratio of Corcept Therapeutics is 67,34
What is the cash to sales ratio of Corcept Therapeutics?
The cash to sales ratio of Corcept Therapeutics is 14,82
What is the reporting currency for Corcept Therapeutics?
Corcept Therapeutics reports financial results in USD
What is the latest annual turnover for Corcept Therapeutics?
The latest annual turnover of Corcept Therapeutics is USD 482,38M
What is the latest annual profit for Corcept Therapeutics?
The latest annual profit of Corcept Therapeutics is USD 106,14M
What is the registered address of Corcept Therapeutics?
The registered address for Corcept Therapeutics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Corcept Therapeutics website address?
The website address for Corcept Therapeutics is www.corcept.com
Which industry sector does Corcept Therapeutics operate in?
Corcept Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
RFACRF Acquisition Corporation
US$ 12,23
(103,49%)
144,36k
RNAZTransCode Therapeutics Inc
US$ 9,1906
(49,20%)
15,45M
ACBAurora Cannabis Inc
US$ 5,345
(45,24%)
60,76M
ASSTAsset Entities Inc
US$ 0,7307
(33,02%)
159,33M
KTTAPasithea Therapeutics Corporation
US$ 2,75
(32,21%)
57,23M
VLCNVolcon Inc
US$ 1,8201
(-43,12%)
3,16M
CSAICloudastructure Inc
US$ 8,155
(-37,17%)
166,64k
LYTLytus Technologies Holdings PTV Ltd
US$ 0,4135
(-31,49%)
928,63k
UPCUniverse Pharmaceuticals Inc
US$ 0,191
(-29,23%)
28,96M
SNAXStryve Foods Inc
US$ 0,553
(-26,07%)
237,75k
CYNCYNGN Inc
US$ 0,08405
(18,38%)
403,31M
RIMEAlgorhythm Holdings Inc
US$ 0,022
(-9,84%)
191,06M
NVDANVIDIA Corporation
US$ 123,8901
(4,42%)
160,6M
ASSTAsset Entities Inc
US$ 0,7307
(33,02%)
159,33M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0508
(15,98%)
87,92M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
CORT
Corcept Therapeutics
BIT
S24948
SG ISSUER
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten